The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
Does Mounjaro Help With Joint Pain?
Joint pain often improves when people lose weight, but neither Mounjaro nor Wegovy directly treats joint pain itself. Both medications work by reducing appetite and supporting weight loss, which can then ease joint stress and pain over time. This guide compares how these two prescription weight loss injections might indirectly help joint health through weight reduction. Understanding the mechanisms and clinical evidence for tirzepatide (Mounjaro) versus semaglutide (Wegovy) will help you and your GP decide which approach might suit your situation best.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
How Weight Loss Supports Joint Health
Joint pain—especially in the knees, hips, and lower back—is often linked to excess weight. When you carry more body weight, your joints bear greater stress and load. Losing even 5–10% of your body weight can significantly reduce joint pain and improve mobility, according to NHS guidance on weight management and osteoarthritis.
Both Mounjaro (tirzepatide, a dual GIP and GLP-1 receptor agonist) and Wegovy (semaglutide, a GLP-1 receptor agonist only) support weight loss by reducing appetite and food cravings. In clinical trials, Mounjaro achieved average weight loss of around 15–21% of body weight, while Wegovy achieved approximately 15% at its maximum dose. The difference in mechanism means some people respond better to one medication than the other—a prescriber will assess which suits you based on your individual health profile and any other medical conditions.
- Weight loss reduces mechanical stress on joints
- Inflammation markers often improve with sustained weight reduction
- Both medications require a structured reduced-calorie diet and increased activity to work effectively
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Mounjaro vs Wegovy for Weight Loss and Joint Pain Relief
Neither Mounjaro nor Wegovy directly treats joint pain or inflammation—they are weight management injections. However, the weight loss they support can indirectly relieve joint pain by reducing load and stress on affected joints. Mounjaro is injected once weekly at doses from 2.5 mg to 15 mg, while Wegovy is also once weekly but at lower doses (0.25 mg to 2.4 mg). A prescriber will decide which is appropriate based on your eligibility, BMI, any weight-related health conditions, and how your body responds. Both are prescription-only medicines available through NHS specialist services or private prescribing in the UK. Use our free GLP-1 weight loss calculator to understand potential weight loss projections at different doses, and check your BMI using our calculator to see if you meet eligibility criteria for these medications.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Can Mounjaro or Wegovy directly reduce joint pain?
No. Neither medication directly treats joint pain or inflammation. However, both support weight loss, which can reduce mechanical stress on joints and ease pain indirectly. For direct joint pain relief, your GP may recommend anti-inflammatory medication, physiotherapy, or other treatments alongside weight management.
How much weight loss is needed to improve joint pain?
Research shows that losing just 5–10% of body weight can significantly reduce joint pain, particularly in the knees and hips. For example, at 80kg, losing 4–8kg may noticeably ease joint discomfort. Sustainable weight loss of 0.5–1 kg per week is the NHS recommendation.
Which is better for joint pain—Mounjaro or Wegovy?
Both medications achieve similar weight loss outcomes on average, so both can indirectly help joint pain through weight reduction. The choice between them depends on your individual circumstances, eligibility, and how your body responds. Your prescriber will assess which is most suitable for you.
Are there any joint-related side effects with Mounjaro or Wegovy?
Neither medication commonly causes joint pain as a side effect. However, some people report muscle or joint aches during the first weeks of treatment. These are usually temporary. Always discuss any new or unusual symptoms with your prescriber or GP.
What else can I do alongside weight loss medication for joint pain?
Combine weight loss with physiotherapy, regular gentle activity (walking, swimming), maintaining a healthy diet, and anti-inflammatory support if recommended by your GP. Losing weight is most effective when combined with structured exercise and lifestyle changes, not medication alone.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.